APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peripheral Neuritis Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Peripheral Neuritis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025198 pages

Choose your research edition.

Industry ResearchPeripheral Neuritis Treatment Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Peripheral Neuritis Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Peripheral Neuritis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peripheral Neuritis Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Peripheral Neuritis Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Peripheral Neuritis Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Peripheral Neuritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Peripheral Neuritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peripheral Neuritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Peripheral Neuritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Peripheral Neuritis Treatment include Teva Pharmaceuticals, Sanofi, Johnson & Johnson, Novartis, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Biogen and Baxter Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Peripheral Neuritis Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Peripheral Neuritis Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Peripheral Neuritis Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Peripheral Neuritis Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Peripheral Neuritis Treatment Segment by Company

Teva Pharmaceuticals

Sanofi

Johnson & Johnson

Novartis

Eli Lilly and Company

Pfizer

GlaxoSmithKline

Biogen

Baxter Healthcare

Depomed

Bristol-Myers Squibb

Peripheral Neuritis Treatment Segment by Type

Idiopathic Peripheral Neuropathy (IPN)

Diabetic Peripheral Neuropathy (DPN)

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Others

Peripheral Neuritis Treatment Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Peripheral Neuritis Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peripheral Neuritis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peripheral Neuritis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peripheral Neuritis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Peripheral Neuritis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peripheral Neuritis Treatment industry.

Chapter 3: Detailed analysis of Peripheral Neuritis Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peripheral Neuritis Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Peripheral Neuritis Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Idiopathic Peripheral Neuropathy (IPN) Table 3. Key Players of Diabetic Peripheral Neuropathy (DPN) Table 4. Key Players of Chemotherapy-induced Peripheral Neuropathy (CIPN) Table 3. Key Players of Others Table 4. Global Peripheral Neuritis Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Pharmacies Table 6. Key Players of Online Pharmacies Table 7. Key Players of Retail Pharmacies Table 8. Global Peripheral Neuritis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Peripheral Neuritis Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Peripheral Neuritis Treatment Market Share by Region (2021-2026) Table 11. Global Peripheral Neuritis Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Peripheral Neuritis Treatment Market Share by Region (2027-2032) Table 13. Peripheral Neuritis Treatment Industry Trends Table 14. Peripheral Neuritis Treatment Industry Drivers Table 15. Peripheral Neuritis Treatment Industry Opportunities and Challenges Table 16. Peripheral Neuritis Treatment Industry Restraints Table 17. Global Peripheral Neuritis Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Peripheral Neuritis Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Peripheral Neuritis Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Peripheral Neuritis Treatment Key Company Head Office and Area Served Table 21. Global Peripheral Neuritis Treatment Company, Product Type & Application Table 22. Global Peripheral Neuritis Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Peripheral Neuritis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Peripheral Neuritis Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Peripheral Neuritis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Peripheral Neuritis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Peripheral Neuritis Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Peripheral Neuritis Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Peripheral Neuritis Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Peripheral Neuritis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Peripheral Neuritis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Peripheral Neuritis Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Peripheral Neuritis Treatment Revenue Market Share by Application (2027-2032) Table 35. Teva Pharmaceuticals Company Information Table 36. Teva Pharmaceuticals Business Overview Table 37. Teva Pharmaceuticals Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Teva Pharmaceuticals Peripheral Neuritis Treatment Product Portfolio Table 39. Teva Pharmaceuticals Recent Development Table 40. Sanofi Company Information Table 41. Sanofi Business Overview Table 42. Sanofi Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Sanofi Peripheral Neuritis Treatment Product Portfolio Table 44. Sanofi Recent Development Table 45. Johnson & Johnson Company Information Table 46. Johnson & Johnson Business Overview Table 47. Johnson & Johnson Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Johnson & Johnson Peripheral Neuritis Treatment Product Portfolio Table 49. Johnson & Johnson Recent Development Table 50. Novartis Company Information Table 51. Novartis Business Overview Table 52. Novartis Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Novartis Peripheral Neuritis Treatment Product Portfolio Table 54. Novartis Recent Development Table 55. Eli Lilly and Company Company Information Table 56. Eli Lilly and Company Business Overview Table 57. Eli Lilly and Company Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Eli Lilly and Company Peripheral Neuritis Treatment Product Portfolio Table 59. Eli Lilly and Company Recent Development Table 60. Pfizer Company Information Table 61. Pfizer Business Overview Table 62. Pfizer Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Pfizer Peripheral Neuritis Treatment Product Portfolio Table 64. Pfizer Recent Development Table 65. GlaxoSmithKline Company Information Table 66. GlaxoSmithKline Business Overview Table 67. GlaxoSmithKline Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. GlaxoSmithKline Peripheral Neuritis Treatment Product Portfolio Table 69. GlaxoSmithKline Recent Development Table 70. Biogen Company Information Table 71. Biogen Business Overview Table 72. Biogen Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Biogen Peripheral Neuritis Treatment Product Portfolio Table 74. Biogen Recent Development Table 75. Baxter Healthcare Company Information Table 76. Baxter Healthcare Business Overview Table 77. Baxter Healthcare Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Baxter Healthcare Peripheral Neuritis Treatment Product Portfolio Table 79. Baxter Healthcare Recent Development Table 80. Depomed Company Information Table 81. Depomed Business Overview Table 82. Depomed Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Depomed Peripheral Neuritis Treatment Product Portfolio Table 84. Depomed Recent Development Table 85. Bristol-Myers Squibb Company Information Table 86. Bristol-Myers Squibb Business Overview Table 87. Bristol-Myers Squibb Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Bristol-Myers Squibb Peripheral Neuritis Treatment Product Portfolio Table 89. Bristol-Myers Squibb Recent Development Table 90. North America Peripheral Neuritis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 91. North America Peripheral Neuritis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 92. North America Peripheral Neuritis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 93. North America Peripheral Neuritis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 94. North America Peripheral Neuritis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Peripheral Neuritis Treatment Market Size by Country (2021-2026) Table 96. North America Peripheral Neuritis Treatment Market Size by Country (2027-2032) Table 97. Europe Peripheral Neuritis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe Peripheral Neuritis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe Peripheral Neuritis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe Peripheral Neuritis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe Peripheral Neuritis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Peripheral Neuritis Treatment Market Size by Country (2021-2026) Table 103. Europe Peripheral Neuritis Treatment Market Size by Country (2027-2032) Table 104. China Peripheral Neuritis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 105. China Peripheral Neuritis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 106. China Peripheral Neuritis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 107. China Peripheral Neuritis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Peripheral Neuritis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia Peripheral Neuritis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia Peripheral Neuritis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia Peripheral Neuritis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Peripheral Neuritis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Peripheral Neuritis Treatment Market Size by Country (2021-2026) Table 114. Asia Peripheral Neuritis Treatment Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Peripheral Neuritis Treatment Product Image Figure 2. Global Peripheral Neuritis Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Peripheral Neuritis Treatment Market Share by Type: 2025 VS 2032 Figure 4. Idiopathic Peripheral Neuropathy (IPN) Image Figure 5. Diabetic Peripheral Neuropathy (DPN) Image Figure 6. Chemotherapy-induced Peripheral Neuropathy (CIPN) Image Figure 7. Others Image Figure 8. Global Peripheral Neuritis Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Peripheral Neuritis Treatment Market Share by Application: 2025 VS 2032 Figure 10. Hospital Pharmacies Image Figure 11. Online Pharmacies Image Figure 12. Retail Pharmacies Image Figure 13. Global Peripheral Neuritis Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 15. Global Peripheral Neuritis Treatment Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Peripheral Neuritis Treatment Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Peripheral Neuritis Treatment Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Peripheral Neuritis Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Peripheral Neuritis Treatment Revenue Market Share by Type (2021-2032) Figure 22. Global Peripheral Neuritis Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Peripheral Neuritis Treatment Revenue Market Share by Application (2021-2032) Figure 24. North America Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 25. North America Peripheral Neuritis Treatment Market Share by Type (2021-2032) Figure 26. North America Peripheral Neuritis Treatment Market Share by Application (2021-2032) Figure 27. North America Peripheral Neuritis Treatment Market Share by Country (2021-2032) Figure 28. United States Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Canada Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Europe Peripheral Neuritis Treatment Market Share by Type (2021-2032) Figure 33. Europe Peripheral Neuritis Treatment Market Share by Application (2021-2032) Figure 34. Europe Peripheral Neuritis Treatment Market Share by Country (2021-2032) Figure 35. Germany Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 36. France Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Italy Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Russia Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 42. China Peripheral Neuritis Treatment Market Share by Type (2021-2032) Figure 43. China Peripheral Neuritis Treatment Market Share by Application (2021-2032) Figure 44. Asia Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 45. Asia Peripheral Neuritis Treatment Market Share by Type (2021-2032) Figure 46. Asia Peripheral Neuritis Treatment Market Share by Application (2021-2032) Figure 47. Asia Peripheral Neuritis Treatment Market Share by Country (2021-2032) Figure 48. Japan Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 52. India Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 53. Australia Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Peripheral Neuritis Treatment Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Peripheral Neuritis Treatment Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Peripheral Neuritis Treatment Market Share by Country (2021-2032) Figure 58. Brazil Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 63. UAE Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Chile Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Idiopathic Peripheral Neuropathy (IPN)
  • Diabetic Peripheral Neuropathy (DPN)
  • Chemotherapy-induced Peripheral Neuropathy (CIPN)
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Teva Pharmaceuticals
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • Biogen
  • Baxter Healthcare
  • Depomed
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Peripheral Neuritis Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Idiopathic Peripheral Neuropathy (IPN)
  5. 1.2.3 Diabetic Peripheral Neuropathy (DPN)
  6. 1.2.4 Chemotherapy-induced Peripheral Neuropathy (CIPN)
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Peripheral Neuritis Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital Pharmacies
  11. 1.3.3 Online Pharmacies
  12. 1.3.4 Retail Pharmacies
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Peripheral Neuritis Treatment Growth Trends by Region
  15. 1.5.1 Global Peripheral Neuritis Treatment Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Peripheral Neuritis Treatment Market Size by Region (2021-2026)
  17. 1.5.3 Peripheral Neuritis Treatment Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Peripheral Neuritis Treatment Market Dynamics
  1. 2.1 Peripheral Neuritis Treatment Industry Trends
  2. 2.2 Peripheral Neuritis Treatment Industry Drivers
  3. 2.3 Peripheral Neuritis Treatment Industry Opportunities and Challenges
  4. 2.4 Peripheral Neuritis Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Peripheral Neuritis Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Peripheral Neuritis Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Peripheral Neuritis Treatment Key Company Head office and Area Served
  4. 3.4 Global Peripheral Neuritis Treatment Company, Product Type & Application
  5. 3.5 Global Peripheral Neuritis Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Peripheral Neuritis Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Peripheral Neuritis Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Peripheral Neuritis Treatment Tier 1, Tier 2, and Tier 3
4 Peripheral Neuritis Treatment Market by Type
  1. 4.1 Global Peripheral Neuritis Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Peripheral Neuritis Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Peripheral Neuritis Treatment Market Size Share by Type (2021-2032)
5 Peripheral Neuritis Treatment Market by Application
  1. 5.1 Global Peripheral Neuritis Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Peripheral Neuritis Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Peripheral Neuritis Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Teva Pharmaceuticals
  2. 6.1.1 Teva Pharmaceuticals Company Information
  3. 6.1.2 Teva Pharmaceuticals Business Overview
  4. 6.1.3 Teva Pharmaceuticals Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Teva Pharmaceuticals Peripheral Neuritis Treatment Product Portfolio
  6. 6.1.5 Teva Pharmaceuticals Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sanofi Peripheral Neuritis Treatment Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Johnson & Johnson Peripheral Neuritis Treatment Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Novartis Peripheral Neuritis Treatment Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Eli Lilly and Company
  26. 6.5.1 Eli Lilly and Company Company Information
  27. 6.5.2 Eli Lilly and Company Business Overview
  28. 6.5.3 Eli Lilly and Company Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Eli Lilly and Company Peripheral Neuritis Treatment Product Portfolio
  30. 6.5.5 Eli Lilly and Company Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Pfizer Peripheral Neuritis Treatment Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 GlaxoSmithKline Peripheral Neuritis Treatment Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Biogen
  44. 6.8.1 Biogen Company Information
  45. 6.8.2 Biogen Business Overview
  46. 6.8.3 Biogen Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Biogen Peripheral Neuritis Treatment Product Portfolio
  48. 6.8.5 Biogen Recent Developments
  49. 6.9 Baxter Healthcare
  50. 6.9.1 Baxter Healthcare Company Information
  51. 6.9.2 Baxter Healthcare Business Overview
  52. 6.9.3 Baxter Healthcare Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Baxter Healthcare Peripheral Neuritis Treatment Product Portfolio
  54. 6.9.5 Baxter Healthcare Recent Developments
  55. 6.10 Depomed
  56. 6.10.1 Depomed Company Information
  57. 6.10.2 Depomed Business Overview
  58. 6.10.3 Depomed Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Depomed Peripheral Neuritis Treatment Product Portfolio
  60. 6.10.5 Depomed Recent Developments
  61. 6.11 Bristol-Myers Squibb
  62. 6.11.1 Bristol-Myers Squibb Company Information
  63. 6.11.2 Bristol-Myers Squibb Business Overview
  64. 6.11.3 Bristol-Myers Squibb Peripheral Neuritis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Bristol-Myers Squibb Peripheral Neuritis Treatment Product Portfolio
  66. 6.11.5 Bristol-Myers Squibb Recent Developments
7 North America
  1. 7.1 North America Peripheral Neuritis Treatment Market Size (2021-2032)
  2. 7.2 North America Peripheral Neuritis Treatment Market Size by Type
  3. 7.2.1 North America Peripheral Neuritis Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Peripheral Neuritis Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Peripheral Neuritis Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Peripheral Neuritis Treatment Market Size by Application
  7. 7.3.1 North America Peripheral Neuritis Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Peripheral Neuritis Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Peripheral Neuritis Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Peripheral Neuritis Treatment Market Size by Country
  11. 7.4.1 North America Peripheral Neuritis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Peripheral Neuritis Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Peripheral Neuritis Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Peripheral Neuritis Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Peripheral Neuritis Treatment Market Size (2021-2032)
  2. 8.2 Europe Peripheral Neuritis Treatment Market Size by Type
  3. 8.2.1 Europe Peripheral Neuritis Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Peripheral Neuritis Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Peripheral Neuritis Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Peripheral Neuritis Treatment Market Size by Application
  7. 8.3.1 Europe Peripheral Neuritis Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Peripheral Neuritis Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Peripheral Neuritis Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Peripheral Neuritis Treatment Market Size by Country
  11. 8.4.1 Europe Peripheral Neuritis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Peripheral Neuritis Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Peripheral Neuritis Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Peripheral Neuritis Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Peripheral Neuritis Treatment Market Size (2021-2032)
  2. 9.2 China Peripheral Neuritis Treatment Market Size by Type
  3. 9.2.1 China Peripheral Neuritis Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Peripheral Neuritis Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Peripheral Neuritis Treatment Market Share by Type (2021-2032)
  6. 9.3 China Peripheral Neuritis Treatment Market Size by Application
  7. 9.3.1 China Peripheral Neuritis Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Peripheral Neuritis Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Peripheral Neuritis Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Peripheral Neuritis Treatment Market Size (2021-2032)
  2. 10.2 Asia Peripheral Neuritis Treatment Market Size by Type
  3. 10.2.1 Asia Peripheral Neuritis Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Peripheral Neuritis Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Peripheral Neuritis Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Peripheral Neuritis Treatment Market Size by Application
  7. 10.3.1 Asia Peripheral Neuritis Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Peripheral Neuritis Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Peripheral Neuritis Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Peripheral Neuritis Treatment Market Size by Country
  11. 10.4.1 Asia Peripheral Neuritis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Peripheral Neuritis Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Peripheral Neuritis Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Peripheral Neuritis Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Peripheral Neuritis Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Peripheral Neuritis Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Peripheral Neuritis Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Peripheral Neuritis Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst